Pain has the strongest case for medical cannabis of any condition we have reviewed, and thin evidence for the part of it we actually measure. Both are true at once, and you deserve them in that order.
What patients are managing
Chronic pain is a qualifying condition under Pennsylvania's medical program, and the phrase covers an enormous range: arthritis, an old back injury, post-surgical pain that never fully left, nerve pain, pain nobody has agreed on a name for. The product sitting on the dispensary shelf knows none of that about you. Closing that gap is the entire job.
What the research supports: cannabinoids
The 2017 National Academies report reached its single strongest therapeutic conclusion here: there is conclusive or substantial evidence that cannabis and cannabinoids are effective for treating chronic pain in adults. That rests on roughly five systematic reviews, anchored by a 2015 analysis covering 28 randomized trials and 2,454 patients. Later syntheses are more tempered. The benefit is real and it is modest, and dizziness, sedation and cognitive effects appear at rates worth knowing about.
What the research supports: terpenes
Now the careful part. Every one of those trials studied cannabinoids, mostly THC. Terpenes, which are what Terpenology reads off your label, have no human pain trial at all. Not one, for any individual terpene. What does exist is animal work, and it is decent animal work: beta-caryophyllene reduced inflammatory pain in mice through the CB2 receptor, and myrcene reduced joint pain and inflammation in rats with arthritis, with the effect blocked when researchers blocked the cannabinoid receptors. A 2024 review in Pharmacological Reviews surveyed the whole terpene analgesia literature and concluded it is predominantly preclinical.
What the research does not support
No terpene has been shown to relieve pain in a human being under trial conditions. If an app tells you a high-myrcene product will treat your back pain, it is extrapolating from rats and not mentioning it. The honest version: myrcene and beta-caryophyllene have a plausible mechanism and real animal support, which is a reason to pay attention and not a reason to expect a result.
How Terpenology scores this
Terpenology shows a pain Fit score at low to moderate confidence and says so on the card rather than in a footnote. The score reads the actual terpene percentages printed on your product's lab panel, weighs them against what the literature supports, and caps itself when the panel is incomplete. It will tell you a product is a poor match for you. That is not a failure of the app. That is the app working.
Terpenes worth reading about
Terpenology is educational, not medical advice. Terpene effects are tendencies commonly reported by patients and early research, never guaranteed outcomes. Nothing here is a substitute for the care of your certifying physician, your pharmacist, or the specialist treating your condition.